申请人:Sage Therapeutics, Inc.
公开号:US11149054B2
公开(公告)日:2021-10-19
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R2, R3, R4, R5, and and R6 are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.
根据式(I)提供化合物:及其药学上可接受的盐,以及其药物组合物;其中 R2、R3、R4、R5 和 R6 如本文所定义。本发明的化合物可用于预防和治疗多种疾病。